Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory A. Gould currently holds 331,255 shares of CytoDyn Inc. (CYDY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory A. Gould has been a net buyer of CYDY stock. They have purchased $100.0K and sold $0 worth of shares.
Gregory A. Gould's most recent insider trade was on Jul 2, 2021, when they sold 73,110 shares at $2.24 per share.
Gregory A. Gould serves as Executive at CytoDyn Inc. (CYDY). They have executed 16 insider transactions totaling $100.0K over their tenure at the company.
Gregory A. Gould holds the position of Executive at CytoDyn Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Gregory A. Gould has shown a buying trading pattern, with $100.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gregory A. Gould was on Jul 2, 2021, when they sold $163.8K worth of NBEV shares. This transaction involved 73,110 shares at $2.24 per share.
Gregory A. Gould currently owns 331,255 shares of CytoDyn Inc. (CYDY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory A. Gould's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory A. Gould has 16 Form 4 filings on record as an insider at CytoDyn Inc..
Set alerts for Gregory A. Gould and 40,000+ other insiders.